These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7985128)

  • 41. Treatment of hairy cell leukemia with alpha-interferon and splenectomy.
    Tominaga S; Watanabe A; Higashi T; Hato S; Itoshima T; Hyodo I; Okushin H; Kita K; Nagashima H
    J Med; 1987; 18(5-6):375-83. PubMed ID: 3505260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon.
    Hagberg H; Hassan I; Glimelius B; Gronowitz S; Källander C; Martinsson U; Sundström C
    Haematologica; 1988; 73(5):365-9. PubMed ID: 3143633
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic approaches to the treatment of hairy cell leukemia.
    Portlock CS
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):55-9. PubMed ID: 3541219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
    Zinzani PL; Stefoni V; Broccoli A; Pellegrini C; Gandolfi L; Casadei B; Maglie R; Pileri S; Argnani L
    Ann Hematol; 2014 Sep; 93(9):1565-9. PubMed ID: 24752417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hairy cell leukemia: follow-up after completion of alpha interferon treatment.
    Castaigne S; Sigaux F; Degos L; Flandrin G
    Nouv Rev Fr Hematol (1978); 1989; 31(5):321-5. PubMed ID: 2587199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hairy cell leukemia. A therapeutical update.
    Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
    Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The therapeutic effect of interferon-alpha exemplified by hairy cell leukemia].
    Schwarzmeier JD
    Wien Med Wochenschr; 1993; 143(16-17):412-5. PubMed ID: 8273363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
    Federico M; Frassoldati A; Pagnucco G; Lamparelli T; Capnist G; Chisesi T; Guarnaccia C; Lauria F; Resegotti L; Rossi G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():179-81. PubMed ID: 2653499
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 51. Hairy cell leukemia--results with alpha interferon therapy.
    Pai S; Shinde SC; Saikia TK; Gopal R; Nair CN; Advani SH
    J Assoc Physicians India; 1999 Jun; 47(6):605-7. PubMed ID: 10999157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O; May D; Wandl U; Niederle N
    Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
    Thompson JA; Shields AF; Porter BA; Olson DO; Rubin E; Kidd P; Fefer A
    Leukemia; 1987 Apr; 1(4):315-6. PubMed ID: 3669752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
    Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
    Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving therapy of hairy cell leukemia.
    Glaspy JA; Jacobs AD; Golde DW
    Cancer; 1987 Feb; 59(3 Suppl):652-7. PubMed ID: 10822465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia.
    Federico M; Chisesi T; Lauria F; Bernasconi C; Capnist G; Castoldi G; Damasio E; Pagnucco G; Frassoldati A; Resegotti L
    Br J Haematol; 1989 May; 72(1):54-6. PubMed ID: 2660901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
    Ozer H; Golomb HM; Zimmerman H; Spiegel RJ
    J Natl Cancer Inst; 1989 Apr; 81(8):594-602. PubMed ID: 2495367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspectives in the treatment of hairy cell leukemia.
    Debusscher L; Stryckmans P
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1095-7. PubMed ID: 3308481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.